Ligustrazine for the Treatment of Unstable Angina: A Meta-Analysis of 16 Randomized Controlled Trials

Evidence-based Complementary and Alternative Medicine

Volumn 2016, Issue , 2016, Pages

  Cao, Suman ^a   Zhao, Wenli ^a,b   Bu, Huaien ^a   Zhao, Ye ^b   Yu, Chunquan ^a  

^a TIANJIN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b Nankai Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN; GLYCERYL TRINITRATE; TETRAMETHYLPYRAZINE;

ALLOPATHY; CONTROL; DATA EXTRACTION; DISABILITY; DRUG EFFECT; DRUG USE; HUMAN; META ANALYSIS (TOPIC); QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW (TOPIC); TERATOGENICITY; UNSTABLE ANGINA PECTORIS; WESTERN MEDICINE;

EID: 84973115802     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2016/8617062     Document Type: Review

References (42)

1. GBD 2013 Mortality and Causes of Death Collaborators, "Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013," The Lancet, vol. 385, no. 9963, pp. 117-171, 2015.
2. P. Bovet and F. Paccaud, "Cardiovascular disease and the changing face of global public health: a focus on low and middle income countries," PublicHealth Reviews, vol. 33,no. 2, pp. 397-415, 2012.
3. P. Bhatnagar, K. Wickramasinghe, J.Williams, M. Rayner, and N. Townsend, "The epidemiology of cardiovascular disease in the UK 2014," Heart, vol. 101, no. 15, pp. 1182-1189, 2015.
4. J. L. Anderson, C. D. Adams, E. M. Antman et al., "ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society ofThoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic EmergencyMedicine," Journal of the American College of Cardiology, vol. 50, no. 7, pp. e1-e157, 2007.
5. C. W. Hamm and E. Braunwald, "A classification of unstable angina revisited," Circulation, vol. 102, no. 1, pp. 118-122, 2000.
6. A. P. Schroeder and E. Falk, "Vulnerable and dangerous coronary plaques," Atherosclerosis, vol. 118, pp. S141-S149, 1995.
7. E. Braunwald, D. B. Mark, R. H. Jones et al., Unstable angina: diagnosis and management. Clinical practice guideline number 10. AHCPR Publication No. 94-0602. Rockville (MD): Agency for Health Care Policy and Research and the National Heart, Lung, and Blood Institute, vol. 154 of Public Health Service, US Department of Health and Human Services, 1994.
8. Institute for Clinical Systems Improvement (ICSI), Health Care Guideline: Diagnosis and Treatment of Chest Pain and Acute Coronary Syndrome (ACS), Institute for Clinical Systems Improvement, Bloomington, Minn, USA, 2012, https://www.icsi.org/asset/ydv4b3/ACS-Interactive1112b.pdf.
9. J. L. Anderson, C. D. Adams, E. M. Antman et al., "2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction a report of the American College of Cardiology Foundation/American Heart Association Task Force on PracticeGuidelines," Circulation, vol. 123, no. 18, pp. e426-e579, 2011.
10. The State Pharmacopoeia Commission of the People's Republic of China, Chinese Pharmacopoeia, vol. 1, Chemical Industry Press, Beijing, China, 2010.
11. C. Y. Kwan, E. E. Daniel, and M. C. Chen, "Inhibition of vasoconstriction by tetramethylpyrazine: does it act by blocking the voltage-dependent Ca channel?" Journal of Cardiovascular Pharmacology, vol. 15, no. 1, pp. 157-162, 1990.
12. K.-L. Wong, P. Chan, W.-C. Huang et al., "Effect of tetramethylpyrazine on potassium channels to lower calcium concentration in cultured aortic smooth muscle cells," Clinical and Experimental Pharmacology and Physiology, vol. 30, no. 10, pp. 793-798, 2003.
13. C.-Y. Kwan, "Plant-derived drugs acting on cellular Ca2+ mobilization in vascular smooth muscle: tetramethylpyrazine and tetrandrine," Stem Cells, vol. 12, no. 1, pp. 64-67, 1994.
14. A. L. S. Au, Y. W. Kwan, C. C. Kwok, R.-Z. Zhang, and G.-W. He, "Mechanisms responsible for the in vitro relaxation of ligustrazine on porcine left anterior descending coronary artery," European Journal of Pharmacology, vol. 468, no. 3, pp. 199-207, 2003.
15. Z. Ren, J.Ma, P. Zhang et al., "Theeffect of ligustrazine on L-type calcium current, calcium transient and contractility in rabbit ventricular myocytes," Journal of Ethnopharmacology, vol. 144, no. 3, pp. 555-561, 2012.
16. X. Gong, V. N. Ivanov, M. M. Davidson, and T. K. Hei, "Tetramethylpyrazine (TMP) protects against sodium arseniteinduced nephrotoxicity by suppressing ROS production, mitochondrial dysfunction, pro-inflammatory signaling pathways and programed cell death," Archives of Toxicology, vol. 89, no. 7, pp. 1057-1070, 2014.
17. F. Jiang, J. Qian, S. Chen, W. Zhang, and C. Liu, "Ligustrazine improves atherosclerosis in rat via attenuation of oxidative stress," Pharmaceutical Biology, vol. 49, no. 8, pp. 856-863, 2011.
18. L. Lv, S.-S. Jiang, J. Xu, J.-B. Gong, and Y. Cheng, "Protective effect of ligustrazine against myocardial ischaemia reperfusion in rats: the role of endothelial nitric oxide synthase," Clinical and Experimental Pharmacology and Physiology, vol. 39, no. 1, pp. 20-27, 2012.
19. R. Fu, Y. Zhang, Y. Guo, Y. Zhang, Y. Xu, and F. Chen, "Digital gene expression analysis of the pathogenesis and therapeutic mechanisms of ligustrazine and puerarin in rat atherosclerosis," Gene, vol. 552, no. 1, pp. 75-80, 2014.
20. E. Braunwald, E. M. Antman, J. W. Beasley et al., "ACC/AHA Guidelines for themanagement of patientswith unstable angina and non-ST-segment elevation myocardial infarction: executive summary and recommendations a report of the American College Of Cardiology/American Heart Association Task Force on Practice Guidelines (committee on the management of patients with unstable angina)," Circulation, vol. 102, no. 10, pp. 1193-1209, 2000.
21. E. Rapaport, "Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the Joint International Society and Federation of Cardiology/World Health Organization task force on standardization of clinical nomenclature," Circulation, vol. 59, no. 3, pp. 607-609, 1979.
22. Chinese Society of Cardiology, "Recommendations for the diagnosis and treatment of unstable angina pectoris," Chinese Journal of Cardiology, vol. 28, no. 6, pp. 409-412, 2000.
23. R. J. Gibbons, K. Chatterjee, J. Daley et al., "ACC/AHA/ACPASIM guidelines for the management of patients with chronic stable angina1: a report of the American College of Cardiology/AmericanHeartAssociation Task Force on PracticeGuidelines (Committee on Management of Patients With Chronic Stable Angina)," Journal of the American College of Cardiology, vol. 33, no. 7, pp. 2092-2197, 1999.
24. J. P. T. Higgins and S. Green, Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0, 2011, http://handbook.cochrane.org/.
25. H. Guo, "Clinical observation of Ligustrazine on unstable angina," Modern Journal of Integrated Traditional Chinese and Western Medicine, vol. 16, no. 29, pp. 4294-4295, 2007.
26. J.-Q. Liao and X.-W. Luo, "Efficacy of Ligustrazine on unstable angina,"Medical Information, vol. 19, no. 7, pp. 1242-1243, 2006.
27. M.-F. Da, "Clinical observation of Ligustrazine on unstable angina," Qinghai Medical Journal, vol. 38, no. 10, pp. 69-70, 2008.
28. W.-M. Rong,W.-Z. Li, and Y.-H.Chen, "Effect of ligustrazine on serum C-reactive protein concentration of patients with unstable angina pectoris," Lingnan Journal of Emergency Medicine, vol. 6, no. 2, pp. 87-93, 2001.
29. L. Peng, "Adjuvant treatment of Ligustrazine injection clinical observation on unstable angina," Modern Journal of Integrated Traditional Chinese and Western Medicine, vol. 23, no. 10, pp. 1108-1110, 2014.
30. Z.-Z.Wang and J.-P. Hua, "Clinical observation of Ligustrazine injection and conventional medicine on unstable angina," Clinical Journal of Traditional ChineseMedicine, vol. 16, no. 5, article 426, 2004.
31. X.-M. Wei, Y. Wen, and M.-F. Ren, "The concentration of vascular endothelial growth factor and clinical observation of ligustrazine injection on unstable angina," Chinese Journal of Cardiovascular Research, vol. 10, no. 3, pp. 181-183, 2012.
32. X.-F. Wang, "Clinical evaluation on the effects of Ligustrazine injection in 65 cases aged with UAP," Research and Practice of Chinese Medicines, vol. 20, no. 3, pp. 56-57, 2006.
33. J.-H. Zhou, "78 cases of high-dose Ligustrazine treatment of unstable angina clinical observation," Journal of Emergency in Traditional ChineseMedicine, vol. 17, no. 11, pp. 1504-1505, 2008.
34. Y. Li, "Evaluation of the clinical diagnosis and treatment of unstable angina medicine," Chinese Journal of Modern Drug Application, vol. 4, no. 9, pp. 113-114, 2010.
35. D.-N. Sun, "Analysis of therapeutic effect of Ligustrazine injection in curing unstable angina," Journal of Practical Medical Techniques, vol. 14, no. 11, pp. 1431-1432, 2007.
36. Q.-Z. Wang, "Clinical research of Ligustrazine injection on unstable angina," Chinese Remedies & Clinics, vol. 5, no. 32, pp. 29-30, 2008.
37. B. Fan, "Efficacy analysis of Ligustrazine injection on elderly unstable angina," Medical Information, vol. 27, no. 3, pp. 484-485, 2014.
38. W.-H. Fu and H. Lin, "Integrative clinical observation of medicine treatment on unstable angina," Chinese Journal of Clinical Rational Drug Use, vol. 2, no. 15, pp. 54-55, 2009.
39. H.-H. Meng, M.-J. Ma, and X. Lin, "Combined low-molecularweight heparins calcium injection with Ligustrazine injection for 76 cases of unstable angina," Clinical Journal of Traditional Chinese Medicine, vol. 17, no. 3, pp. 255-256, 2005.
40. F. Wang, W.-Q. Gu, and J. Bai, "The clinical observation of combined nitroglycerin with Ligustrazine injection for 32 cases on unstable angina," Chinese Journal of Integrative Medicine on Cardiovascular Disease, vol. 3, no. 1, article 78, 2005.
41. The State Pharmacopoeia Commission of the People's Republic of China, Chinese Pharmacopoeia, vol. 2, Chemical Industry Press, Beijing, China, 2015.
42. F. K.-H. Sze, F. F. Yeung, E. Wong, and J. Lau, "Does Danshen improve disability after acute ischaemic stroke?" Acta Neurologica Scandinavica, vol. 111, no. 2, pp. 118-125, 2005.